TLDR:
Key Points:
- Alberta Enterprise Corporation invests US$7.5 million into Amplitude Ventures’ Fund II
- Amplitude Ventures is a full-stack venture capital firm focused on precision medicine
In a recent announcement, Alberta Enterprise Corporation (AEC) invested US$7.5 million into Amplitude Ventures’ US$192 million Fund II. This investment aims to support early stage Alberta health and life science startups by providing access to Amplitude’s specialized precision medicine expertise and investment. Amplitude Ventures, a venture capital firm focused on precision medicine at the intersection of biology and AI, has a track record of investing in pioneers in precision health companies since 2019.
With the establishment of a full-time presence in Alberta, Amplitude Ventures, led by partners Dion Madsen, Jean-Francois Pariseau, Ali Tehrani, and venture partner Nancy Harrison, is committed to supporting Alberta entrepreneurs in building new precision medicine companies that can drive significant advancements in human health. The firm’s strategic partnership with Alberta-based AltaML in 2022 further solidified its connection to the region.
The hire of Nadia Lachman as a full-time investor based in Calgary underscores Amplitude’s dedication to furthering its presence in Alberta and providing local startups with the necessary resources for growth. With a focus on combining AI and biotech knowledge, Amplitude Ventures aims to support emerging health startups and contribute to the success of research projects coming out of Alberta’s universities.
Alberta Enterprise Corporation’s investment in Amplitude’s Fund II signifies a continued partnership aimed at fostering innovation in precision medicine within Alberta’s growing AI and biotech ecosystem. The collaboration between AEC and Amplitude Ventures is set to drive the future of healthcare and create opportunities for transformative advancements in the life sciences sector.
